Related references
Note: Only part of the references are listed.Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510
Ryan J. Keenan et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem
Seonghae Yoon et al.
SCIENTIFIC REPORTS (2021)
Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant
Carsten T. Beuckmann et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors
Chanung Wang et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Hypnotics with novel modes of action
Daniel Hoyer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice
Fang Zhou et al.
NEUROBIOLOGY OF AGING (2020)
Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial
Thomas C. Neylan et al.
SLEEP (2020)
Effects of orexin receptor antagonism on human sleep architecture: A systematic review
Jacob W. Clark et al.
SLEEP MEDICINE REVIEWS (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration
C. M. Holton et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
Jerrah K. Holth et al.
SCIENCE (2019)
Validation of 'Somnivore', a Machine Learning Algorithm for Automated Scoring and Analysis of Polysomnography Data
Giancarlo Allocca et al.
FRONTIERS IN NEUROSCIENCE (2019)
Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
Julia Gamache et al.
NATURE COMMUNICATIONS (2019)
Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable
James R. Docherty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
Kasper Recourt et al.
TRANSLATIONAL PSYCHIATRY (2019)
Large-scale discovery of mouse transgenic integration sites reveals frequent structural variation and insertional mutagenesis
Leslie O. Goodwin et al.
GENOME RESEARCH (2019)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
Yan Zhu et al.
JOURNAL OF NEUROSCIENCE (2018)
The release and trans-synaptic transmission of Tau via exosomes
Yipeng Wang et al.
MOLECULAR NEURODEGENERATION (2017)
Altered sleep and EEG power in the P301S Tau transgenic mouse model
Jerrah K. Holth et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Neuronal activity enhances tau propagation and tau pathology in vivo
Jessica W. Wu et al.
NATURE NEUROSCIENCE (2016)
Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology
David J. Koss et al.
NEUROBIOLOGY OF DISEASE (2016)
Alcohol and Aldehyde Dehydrogenases Contribute to Sex-Related Differences in Clearance of Zolpidem in Rats
Cody J. Peer et al.
FRONTIERS IN PHARMACOLOGY (2016)
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter et al.
SCIENTIFIC REPORTS (2016)
Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep
Michael D. Schwartz et al.
ENEURO (2016)
Sleep Interacts with Aβ to Modulate Intrinsic Neuronal Excitability
Masashi Tabuchi et al.
CURRENT BIOLOGY (2015)
Assessment and management of behavioral and psychological symptoms of dementia
Helen C. Kales et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Assessment and management of behavioral and psychological symptoms of dementia
Helen C. Kales et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2014)
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
C. J. Winrow et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Discovery of 5-Chloro-N-[( 5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia
Anthony J. Roecker et al.
CHEMMEDCHEM (2014)
Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease
Jee Hoon Roh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Neuronal activity regulates extracellular tau in vivo
Kaoru Yamada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Sleep and Alzheimer disease pathology-a bidirectional relationship
Yo-El S. Ju et al.
NATURE REVIEWS NEUROLOGY (2014)
Suvorexant for the treatment of insomnia
Laura H. Jacobson et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
Stephen R. Morairty et al.
FRONTIERS IN NEUROSCIENCE (2014)
The sleep-wake cycle and Alzheimer's disease: what do we know?
Miranda M. Lim et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2014)
Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Claudia Betschart et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniel Hoyer et al.
NEUROPEPTIDES (2013)
Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats
Steven V. Fox et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Sleep Drives Metabolite Clearance from the Adult Brain
Lulu Xie et al.
SCIENCE (2013)
Distinct effects of IPSU and suvorexant on mouse sleep architecture
Daniel Hoyer et al.
FRONTIERS IN NEUROSCIENCE (2013)
Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of Amyloid-β in Mice with Alzheimer's Disease Pathology
Jee Hoon Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
Geraldine M. Mang et al.
SLEEP (2012)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy
Mei Yue et al.
NEUROBIOLOGY OF AGING (2011)
Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat
Michel A. Steiner et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
SLEEP The memory function of sleep
Susanne Diekelmann et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Jae-Eun Kang et al.
SCIENCE (2009)
Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
John R. Cirrito et al.
NEURON (2008)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Diurnal sex differences in the sleep-wake cycle of mice are dependent on gonadal function
Ketema N. Paul et al.
SLEEP (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Share Paper
